Eurointervention

Papers
(The H4-Index of Eurointervention is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity203
In search of the origin of the acronym TAVI167
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis151
Double-tap to treat paravalvular leak in high-risk annuli144
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation120
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry100
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement83
Transcatheter left ventriculoplasty71
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s71
Recanalisation of coronary chronic total occlusions61
Defer-based non-stenting: a promising approach for STEMI60
The “road travelled”: reflections on the transformation of information exchange in a digital age55
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure55
   Atrial fibrillation and acute coronary syndrome 51
One-month DAPT after acute coronary syndrome: too short or not too short?49
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study49
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve49
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection45
Hybrid coronary revascularisation: the best or the worst of both worlds?41
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document40
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudy39
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes36
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial36
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD36
Redo transcatheter mitral valve replacement in mitral annular calcification36
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement34
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study34
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons32
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study31
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial31
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation30
0.085602045059204